335 related articles for article (PubMed ID: 30052811)
1. Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society-USA Panel.
Günthard HF; Calvez V; Paredes R; Pillay D; Shafer RW; Wensing AM; Jacobsen DM; Richman DD
Clin Infect Dis; 2019 Jan; 68(2):177-187. PubMed ID: 30052811
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.
Hirsch MS; Günthard HF; Schapiro JM; Brun-Vézinet F; Clotet B; Hammer SM; Johnson VA; Kuritzkes DR; Mellors JW; Pillay D; Yeni PG; Jacobsen DM; Richman DD
Clin Infect Dis; 2008 Jul; 47(2):266-85. PubMed ID: 18549313
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.
Hirsch MS; Brun-Vézinet F; Clotet B; Conway B; Kuritzkes DR; D'Aquila RT; Demeter LM; Hammer SM; Johnson VA; Loveday C; Mellors JW; Jacobsen DM; Richman DD
Clin Infect Dis; 2003 Jul; 37(1):113-28. PubMed ID: 12830416
[TBL] [Abstract][Full Text] [Related]
4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.
Thompson MA; Aberg JA; Hoy JF; Telenti A; Benson C; Cahn P; Eron JJ; Günthard HF; Hammer SM; Reiss P; Richman DD; Rizzardini G; Thomas DL; Jacobsen DM; Volberding PA
JAMA; 2012 Jul; 308(4):387-402. PubMed ID: 22820792
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.
Günthard HF; Saag MS; Benson CA; del Rio C; Eron JJ; Gallant JE; Hoy JF; Mugavero MJ; Sax PE; Thompson MA; Gandhi RT; Landovitz RJ; Smith DM; Jacobsen DM; Volberding PA
JAMA; 2016 Jul; 316(2):191-210. PubMed ID: 27404187
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.
Hirsch MS; Brun-Vézinet F; D'Aquila RT; Hammer SM; Johnson VA; Kuritzkes DR; Loveday C; Mellors JW; Clotet B; Conway B; Demeter LM; Vella S; Jacobsen DM; Richman DD
JAMA; 2000 May; 283(18):2417-26. PubMed ID: 10815085
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy.
Svärd J; Mugusi S; Mloka D; Neogi U; Meini G; Mugusi F; Incardona F; Zazzi M; Sönnerborg A
PLoS One; 2017; 12(6):e0178942. PubMed ID: 28582463
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
Saag MS; Gandhi RT; Hoy JF; Landovitz RJ; Thompson MA; Sax PE; Smith DM; Benson CA; Buchbinder SP; Del Rio C; Eron JJ; Fätkenheuer G; Günthard HF; Molina JM; Jacobsen DM; Volberding PA
JAMA; 2020 Oct; 324(16):1651-1669. PubMed ID: 33052386
[TBL] [Abstract][Full Text] [Related]
10. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.
Hirsch MS; Conway B; D'Aquila RT; Johnson VA; Brun-Vézinet F; Clotet B; Demeter LM; Hammer SM; Jacobsen DM; Kuritzkes DR; Loveday C; Mellors JW; Vella S; Richman DD
JAMA; 1998 Jun; 279(24):1984-91. PubMed ID: 9643863
[TBL] [Abstract][Full Text] [Related]
12. Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
Memarnejadian A; Menbari S; Mansouri SA; Sadeghi L; Vahabpour R; Aghasadeghi MR; Mostafavi E; Abdi M
PLoS One; 2015; 10(5):e0126955. PubMed ID: 25962088
[TBL] [Abstract][Full Text] [Related]
13. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
De Luca A; Hamers RL; Schapiro JM
J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
[TBL] [Abstract][Full Text] [Related]
14. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Kityo C; Steegen K; Naniche D; Clotet B; Rinke de Wit TF; Paredes R;
Lancet HIV; 2018 Nov; 5(11):e638-e646. PubMed ID: 30282603
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.
Yeni PG; Hammer SM; Carpenter CC; Cooper DA; Fischl MA; Gatell JM; Gazzard BG; Hirsch MS; Jacobsen DM; Katzenstein DA; Montaner JS; Richman DD; Saag MS; Schechter M; Schooley RT; Thompson MA; Vella S; Volberding PA
JAMA; 2002 Jul; 288(2):222-35. PubMed ID: 12095387
[TBL] [Abstract][Full Text] [Related]
17. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
18. [GESIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)].
Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):543.e1-43. PubMed ID: 25959461
[TBL] [Abstract][Full Text] [Related]
19. Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay.
Silver N; Paynter M; McAllister G; Atchley M; Sayir C; Short J; Winner D; Alouani DJ; Sharkey FH; Bergefall K; Templeton K; Carrington D; Quiñones-Mateu ME
AIDS Res Ther; 2018 Nov; 15(1):18. PubMed ID: 30409215
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.
Saag MS; Benson CA; Gandhi RT; Hoy JF; Landovitz RJ; Mugavero MJ; Sax PE; Smith DM; Thompson MA; Buchbinder SP; Del Rio C; Eron JJ; Fätkenheuer G; Günthard HF; Molina JM; Jacobsen DM; Volberding PA
JAMA; 2018 Jul; 320(4):379-396. PubMed ID: 30043070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
